You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • AB0325 Comparison of The Efficacy of Second Tnf Inhibitor versus Alternative Biological Agent (Rituximab/Tocilizumab/Abatacept) after Secondary Failure To Initial Anti TNF Therapy in Rheumatoid Arthritis – A Retrospective Observational Analysis

Citation Tools

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - anti-TNF therapy
AB0325 Comparison of The Efficacy of Second Tnf Inhibitor versus Alternative Biological Agent (Rituximab/Tocilizumab/Abatacept) after Secondary Failure To Initial Anti TNF Therapy in Rheumatoid Arthritis – A Retrospective Observational Analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shipa M, Di Cicco M, Roussou E
AB0325 Comparison of The Efficacy of Second Tnf Inhibitor versus Alternative Biological Agent (Rituximab/Tocilizumab/Abatacept) after Secondary Failure To Initial Anti TNF Therapy in Rheumatoid Arthritis – A Retrospective Observational Analysis
Annals of the Rheumatic Diseases 2016;75:1012.